Zydus Pharmaceuticals USA Inc recalls Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 6838…
- Recall date
- July 19, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1461-2016
- FDA classification
- Class II
- Brand / firm
- Zydus Pharmaceuticals USA Inc
- Sold / distributed
- Nationwide
Why it was recalled
Failed Dissolution Specifications: out of specification dissolution results in retained samples
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.
Get recall alerts
Free email alert whenever Zydus Pharmaceuticals USA Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Zydus Pharmaceuticals USA Inc